Everhope Oncology takes the anxiety out of cancer treatment — with zero wait time, 2X faster service, pre-booked diagnostics, and personalised concierge-led assistance.

GURUGRAM, India, Aug. 6, 2025 /PRNewswire/ -- Everhope Oncology, a next-generation cancer care platform backed by Narayana Health, W Health Ventures, and 2070 Health, today announced the launch of its first 15-bed dedicated cancer daycare centre in Sector 65, Gurugram. Situated strategically on Golf Course Extension Road, this state-of-the-art facility transforms how cancer care is delivered in India — especially for cancer patients who desire seamless, personalized treatment without compromising their quality of life. Everhope provides clinical excellence in a non-hospital, healing-led environment. More than a facility, Everhope is a bold movement to redefine cancer care — from fear and confusion to clarity, convenience, and dignity.

"This is not just a launch of another healthcare facility. It's a response to what millions of Indian patients need — accessible, dignified cancer care that doesn't uproot their entire lives," said Gaurav Porwal, Director, Everhope Oncology. "We are solving India's cancer care gaps by reimagining the entire experience — from long queues and hospital overwhelm to a centre that's calm, close to home, and clinically world-class. Our daycare model eliminates the logistical and emotional barriers that often delay or complicate treatment. Patients can receive their chemotherapy in the morning and return to their normal activities by afternoon. And, what also sets us apart is our focus on personalized nutrition guidance from functional medicine experts, tailored to each patient's unique needs. This expert support not only aids recovery but also helps optimize treatment outcomes — ensuring that every patient receives holistic care, not just medical intervention. With the demand for 40,000 new cancer beds projected in India over the next few years, we believe the Everhope model is timely, viable, and scalable." Cancer care is evolving — globally and in India. While earlier, treatments required long hospital stays and multiple visits to distant tertiary centres, the daycare model is now considered the gold standard in high-income countries. Over 60% of chemotherapy and immunotherapy sessions worldwide are delivered via daycare — enabling patients to recover at home, maintain routine, and reduce exposure to hospital-borne infections.

India, however, faces a growing cancer burden — with 8 million+ active cases, and 1 in 9 Indians projected to develop cancer in their lifetime. Coupled with a doctor-patient ratio of 1 oncologist for every 2,000 patients, delays in diagnosis and treatment are common. Everhope bridges this critical gap by bringing precision oncology closer to the patient, while reducing logistical stress and psychological barriers.

"Our clinical offering isn't just comprehensive — it's cohesive," said Dr. Sunny Garg, Chief Medical Officer, Everhope Oncology. "With a high-powered Tumor Board, protocol adherence, and patient tracking systems, we ensure every treatment is tailored, evidence-backed, and emotionally intelligent. Whether it's immunotherapy, palliative care, or integrative support — we aim to deliver world-class outcomes centred around the patients in a neighbourhood setting. Cancer patients shouldn't have to choose between world-class treatment and maintaining their quality of life. Our daycare model recognizes that these patients want to continue working, spending time with family, and sleeping in their own beds. Research shows that outpatient chemotherapy not only maintains equivalent clinical outcomes but often improves patient satisfaction and psychological well-being." Everhope Oncology raised $10 million in seed funding, making it one of the largest early-stage investments in Indian healthcare in recent years. The joint venture brings together clinical excellence from Narayana Health, venture innovation from W Health, and GTM and Technology capabilities from 2070 Health. After the successful launch of the Gurugram centre, Everhope plans to open additional centres across NCR, including South Delhi and Noida in the coming months. The brand is also finalising locations in Mumbai and Bangalore, with a 10-city expansion roadmap planned over the next three years. With a mission to deliver 100,000+ cancer sessions over the next 36 months, Everhope is poised to reshape how India treats, manages, and overcomes cancer — with dignity, speed, and strength.

Everhope's unique edge • 15-bed private suites designed for chemotherapy and targeted therapy • 24x7 patient concierge support for appointment management and care continuity • 2x time saving at every stage from diagnostics to therapy, during consultation, billing and also parking • On-demand diagnostics with pre-booked lab & imaging services • Financial assistance cell for insurance, EMIs, and cost transparency • A Super Specialist Tumor Board of oncologists across medical, surgical, and radiation specialties • Precision Oncology Pathways with protocol-driven care and clinical audits • Mental health Emotional support and counselling for patients and next of kin • Customised Nutrition: Patients receive tailored meal plans designed by onco-nutrition experts to aid recovery and boost immunity About Everhope Oncology: Everhope is India's first specialised cancer daycare brand committed to transforming how cancer care is experienced and delivered. It's focused on delivering holistic, localised, and emotionally intelligent oncology care. From chemotherapy to counselling, diagnostics to diet, Everhope builds a 360-degree support ecosystem — centred entirely around the patient.

Everhope Oncology is India's first patient-first, technology-enabled cancer daycare platform committed to transforming how cancer care is experienced and delivered. Founded in 2025 as a joint venture between Narayana Health, W Health Ventures, and 2070 Health, Everhope focuses on delivering high-quality, decentralised cancer treatment through accessible, emotionally intelligent, and clinically robust facilities.

Each Everhope centre is designed to offer same-day chemotherapy, immunotherapy, diagnostics, nutrition, mental health counselling, and concierge support — all under one roof. With zero wait times, expert-led tumor boards, and integrated care pathways, Everhope aims to reduce the logistical, financial, and emotional burdens typically associated with cancer treatment.

The brand's vision is to expand across 10 cities in the next three years, bringing compassionate, world-class oncology care closer to where people live and work.

For more information, visit: https://everhope.care/ (Disclaimer: The above press release comes to you under an arrangement with PRNewswire and PTI takes no editorial responsibility for the same.). PTI PWR PWR